Is HIV a model of accelerated or accentuated aging?
Background. Antiretroviral therapy has reduced the incidence of adverse events and early
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
[PDF][PDF] Is HIV a Model of Accelerated or Accentuated Aging?
S Pathai, H Bajillan, AL Landay, KP High - 2013 - natap.org
Background. Antiretroviral therapy has reduced the incidence of adverse events and early
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
Is HIV a model of accelerated or accentuated aging?
S Pathai, H Bajillan, AL Landay… - … of Gerontology-Series …, 2014 - researchexperts.utmb.edu
Background. Antiretroviral therapy has reduced the incidence of adverse events and early
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
Is HIV a Model of Accelerated or Accentuated Aging?
S Pathai, H Bajillan, AL Landay… - Journals of Gerontology …, 2014 - search.ebscohost.com
Background. Antiretroviral therapy has reduced the incidence of adverse events and early
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
[HTML][HTML] Editor's choice: Is HIV a Model of Accelerated or Accentuated Aging?
S Pathai, H Bajillan, AL Landay… - The Journals of …, 2014 - ncbi.nlm.nih.gov
Background. Antiretroviral therapy has reduced the incidence of adverse events and early
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
Is HIV a model of accelerated or accentuated aging?
S Pathai, H Bajillan, AL Landay… - The Journals of …, 2013 - europepmc.org
Background Antiretroviral therapy has reduced the incidence of adverse events and early
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
[PDF][PDF] Is HIV a Model of Accelerated or Accentuated Aging?
S Pathai, H Bajillan, AL Landay, KP High - 2013 - natap.org
Background. Antiretroviral therapy has reduced the incidence of adverse events and early
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
Is HIV a model of accelerated or accentuated aging?
S Pathai, H Bajillan, AL Landay… - The journals of …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Antiretroviral therapy has reduced the incidence of adverse events and early
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
[PDF][PDF] Is HIV a Model of Accelerated or Accentuated Aging?
S Pathai, H Bajillan, AL Landay, KP High - 2013 - natap.org
Background. Antiretroviral therapy has reduced the incidence of adverse events and early
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
[PDF][PDF] Is HIV a Model of Accelerated or Accentuated Aging?
S Pathai, H Bajillan, AL Landay, KP High - 2013 - natap.org
Background. Antiretroviral therapy has reduced the incidence of adverse events and early
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …